The dollar weakened against the yen, with USD/JPY falling 0.8% to 145.20 as markets responded to softer U.S. inflation data and Japan's surprisingly resilient GDP growth of 0.2% in Q1, which significantly outperformed expectations of a 1.1% contraction.
Diverging Central Bank Policies
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile appBoJ Deputy Governor Shinichi Uchida reaffirmed the central bank's hawkish stance, stating they "will keep raising rates if the economy and prices improve as projected." This contrasts with the Federal Reserve's increasingly dovish outlook after April's CPI edged down to 2.3% year-on-year. Markets have now priced in approximately 56 basis points of Fed rate cuts by December 2025, up from 49 basis points previously expected.
Trade Relations and Outlook
The 90-day U.S.-China tariff reduction agreement initially sparked optimism, but concerns persist about long-term trade policy. Japanese Prime Minister Shigeru Ishiba has opposed any U.S. trade deal excluding automobile provisions, highlighting potential challenges for Japan's exports. The dollar's medium-term outlook against the yen appears increasingly bearish as the monetary policy divergence strengthens, with Goldman Sachs revising its three-month USD/JPY target to 142.50.
USDJPY (D1)
The USDJPY is currently trading around its 30-day EMA, a key short-term level. Bulls will aim to break above the 50-day EMA at 145.82 to regain control, while bears are eyeing a retest of the previous lows at 142.390. The RSI is on the verge of breaking a bullish divergence, suggesting potential weakness in momentum. Meanwhile, the MACD is tightening, signaling indecision and calling for caution in the near term.

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.